HALOPERIDOL Safety Questions, HALOPERIDOL Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about HALOPERIDOL. Our extensive database of HALOPERIDOL adverse events and HALOPERIDOL warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about HALOPERIDOL

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




HALOPERIDOL Safety Reports

Total HALOPERIDOL reports: 122.
HALOPERIDOL FDA safety alerts: 2007 .
Reported deaths: 28    Reported hospitalizations: 48.
Take HALOPERIDOL Side Effects Survey or Share Your HALOPERIDOL Story. HALOPERIDOL Usage.

Showing 1-75 of 122 Next >

Pharmacist from UNITED STATES reported HALOPERIDOL problem on Oct 19, 2006. Female patient, 57 years of age, was diagnosed with psychotic disorder and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: drooling, tremor. HALOPERIDOL dosage: HALOPERIDOL 1 MG PO BID. Patient recovered.

HALOPERIDOL problem was reported by a Physician from BRAZIL on Oct 15, 2006. Female patient, child 2 years of age, was diagnosed with accidental exposure and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: extrapyramidal disorder. HALOPERIDOL dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported HALOPERIDOL problem on Oct 16, 2006. Male patient, weighting 149.9 lb, was diagnosed with acute psychosis and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: overdose. HALOPERIDOL dosage: unknown. During the same period patient was treated with HALOPERIDOL DECANOATE. Patient was hospitalized. Patient recovered.

HALOPERIDOL problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 19, 2006. Female patient was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, dysphagia, speech disorder. HALOPERIDOL dosage: unknown. Patient was hospitalized. Patient recovered.

Health Professional from UNITED KINGDOM reported HALOPERIDOL problem on Feb 05, 2004. Male patient, 28 years of age, was diagnosed with schizophrenia and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: aortic arteriosclerosis, cardiac failure, cardiomegaly, circulatory collapse, congestive cardiomyopathy, coronary artery disease, dilatation ventricular, ejection fraction decreased, exercise tolerance decreased. HALOPERIDOL dosage: unknown. During the same period patient was treated with METFORMIN, GLICLAZIDE, SALBUTAMOL INHALANT, CLOZARIL. Patient was hospitalized. Patient died on 06/22/2005.

HALOPERIDOL problem was reported by a Health Professional from UNITED KINGDOM on Feb 05, 2004. Male patient, 28 years of age, was diagnosed with schizophrenia and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: aortic arteriosclerosis, cardiac failure, cardiomegaly, circulatory collapse, congestive cardiomyopathy, coronary artery disease, dilatation ventricular, ejection fraction decreased, exercise tolerance decreased. HALOPERIDOL dosage: unknown. During the same period patient was treated with METFORMIN, GLICLAZIDE, SALBUTAMOL INHALANT, CLOZARIL. Patient was hospitalized. Patient died on 06/22/2005.

Pharmacist from UNITED STATES reported HALOPERIDOL problem on Nov 02, 2006. Male patient, weighting 167.6 lb, was diagnosed with schizophrenia and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, constipation, eschar, escherichia urinary tract infection, faecal incontinence, mental status changes, pneumonia, urinary incontinence. HALOPERIDOL dosage: HALOPERIDOL 5MG EVERY SIX HOURS PO. During the same period patient was treated with OLANZAPINE. Patient was hospitalized. Patient recovered.

HALOPERIDOL problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 02, 2006. Male patient, 36 years of age, weighting 198.0 lb, was diagnosed with bipolar i disorder and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: biliary tract disorder, hepatitis viral, pancreatitis. HALOPERIDOL dosage: unknown. During the same period patient was treated with FLUOXETINE HYDROCHLORIDE, ZYPREXA. Patient was hospitalized. Patient recovered.

Physician from SPAIN reported HALOPERIDOL problem on Oct 04, 2006. Male patient, 71 years of age, was diagnosed with hallucination, visual, cognitive disorder and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: bradyphrenia, depressed level of consciousness, dysphagia, parkinsonism. HALOPERIDOL dosage: unknown. Patient recovered.

HALOPERIDOL problem was reported by a Physician from NETHERLANDS on Oct 28, 2006. Male patient, 45 years of age, was diagnosed with schizophrenia, paranoid type and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: inappropriate antidiuretic hormone secretion. HALOPERIDOL dosage: unknown. During the same period patient was treated with QUETIAPINE FUMARATE. Patient recovered.

Pharmacist from UNITED STATES reported HALOPERIDOL problem on Nov 16, 2006. Male patient, 81 years of age, weighting 165.0 lb, was diagnosed with delirium and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: agitation, cardiac arrest, delirium, dementia, torsade de pointes, ventricular fibrillation. HALOPERIDOL dosage: unknown. Patient recovered.

HALOPERIDOL problem was reported by a Pharmacist from UNITED STATES on Nov 20, 2006. Male patient, 38 years of age, weighting 200.0 lb, was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: akathisia, extrapyramidal disorder, tremor. HALOPERIDOL dosage: 100MG Q4WEEKS IM. Patient recovered.

Physician from UNITED STATES reported HALOPERIDOL problem on Oct 24, 2006. Female patient, 52 years of age, was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: completed suicide. HALOPERIDOL dosage: unknown. During the same period patient was treated with NORTRIPTYLINE, OXCARBAZEPINE. Patient died.

HALOPERIDOL problem was reported by a Physician from UNITED STATES on Oct 24, 2006. Male patient, 20 years of age, was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, completed suicide, heart rate increased, refusal of treatment by patient. HALOPERIDOL dosage: unknown. During the same period patient was treated with NORTRIPTYLINE, ASPIRIN. Patient died.

Physician from UNITED STATES reported HALOPERIDOL problem on Oct 24, 2006. Female patient, 29 years of age, was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, respiratory arrest. HALOPERIDOL dosage: unknown. During the same period patient was treated with AMITRIPTYLINE, ZIPRASIDONE. Patient died.

HALOPERIDOL problem was reported by a Health Professional from UNITED KINGDOM on Nov 13, 2006. Female patient, 68 years of age, weighting 121.3 lb, was diagnosed with anxiety, agitation, depression and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: akathisia. HALOPERIDOL dosage: unknown. During the same period patient was treated with LITHIUM CARBONATE, LOFEPRAMINE, MIRTAZAPINE, TRAZODONE. Patient recovered.

Health Professional from ROMANIA reported HALOPERIDOL problem on Nov 16, 2006. Male patient, weighting 163.1 lb, was diagnosed with psychotic disorder, agitation and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: schizophrenia, paranoid type. HALOPERIDOL dosage: unknown. During the same period patient was treated with HALOPERIDOL DECANOATE, HALOPERIDOL DECANOATE, DIAZEPAM. Patient was hospitalized. Patient recovered.

HALOPERIDOL problem was reported by a Health Professional from IRELAND on Nov 14, 2006. Female patient, 68 years of age, was diagnosed with vomiting, nausea and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: bradykinesia, cogwheel rigidity, hypercalcaemia, masked facies, musculoskeletal stiffness, salivary hypersecretion. HALOPERIDOL dosage: unknown. During the same period patient was treated with CYCLIZINE. Patient was hospitalized and became disabled. Patient recovered.

Physician from UNITED STATES reported HALOPERIDOL problem on Nov 13, 2006. Female patient, 51 years of age, was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, blood pressure diastolic decreased, hypertension, ileus paralytic, intentional overdose, lethargy, mental impairment, sinus tachycardia. HALOPERIDOL dosage: unknown. During the same period patient was treated with RISPERDONE, ACETAMINOPHEN, BENZTROPINE MESYLATE. Patient died.

HALOPERIDOL problem was reported by a Physician from UNITED STATES on Nov 13, 2006. Male patient, 20 years of age, was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, heart rate increased, refusal of treatment by patient. HALOPERIDOL dosage: unknown. During the same period patient was treated with NORTRIPTYLINE, ACETYLSALICYLIC ACID SRT. Patient died.

Consumer or non-health professional from UNITED STATES reported HALOPERIDOL problem on Mar 02, 2006. Female patient, 57 years of age, weighting 279.9 lb, was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: biliary tract disorder, blood cholesterol abnormal, cardiac failure congestive, diabetes mellitus non-insulin-dependent, hypertension, metabolic disorder, myocardial infarction, myocardial ischaemia, pulmonary embolism. HALOPERIDOL dosage: unknown. During the same period patient was treated with CARBAMAZEPINE, SERTRALINE, ACEBUTOLOL, PROPRANOLOL, ESTROGENS CONJUGATED W, ZYPREXA. Patient was hospitalized. Patient recovered.

HALOPERIDOL problem was reported by a Physician from NETHERLANDS on Nov 14, 2006. Male patient, 45 years of age, was diagnosed with schizophrenia, paranoid type and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: anxiety, complicated fracture, contusion, fall, inappropriate antidiuretic hormone secretion, mental disorder, radius fracture, rib fracture, spinal fracture. HALOPERIDOL dosage: 2.5 MG TID UNK. During the same period patient was treated with QUETIAPINE FUMARATE, QUESTIAPINE, MIDAZOLAM HYDROCHLORIDE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported HALOPERIDOL problem on Mar 02, 2006. Male patient, 58 years of age, weighting 467.4 lb, was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: blood cholesterol abnormal, blood triglycerides increased, cardiac operation, diabetes mellitus, glycosuria, myocardial ischaemia, vision blurred. HALOPERIDOL dosage: unknown. During the same period patient was treated with ZYPREXA. Patient was hospitalized. Patient recovered.

HALOPERIDOL problem was reported by a Physician from BRAZIL on Dec 08, 2006. Male patient, 24 years of age, weighting 176.4 lb, was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: overdose, somnolence, suicide attempt. HALOPERIDOL dosage: unknown. During the same period patient was treated with CARBAMAZEPINE, ETHANOL. Patient recovered.

Pharmacist from UNITED STATES reported HALOPERIDOL problem on Nov 29, 2006. Male patient, 35 years of age, weighting 269.0 lb, was diagnosed with schizophrenia and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: disease recurrence, psychotic disorder. HALOPERIDOL dosage: 5 MG (5 MG/ML), INTRAMUSCULAR. During the same period patient was treated with RISPERIDONE, CLOZAPINE, VALPROATE, FLUOXETINE HYDROCHLORIDE. Patient died on 07/07/2006.

HALOPERIDOL problem was reported by a Pharmacist from FRANCE on Dec 12, 2006. Female patient, 75 years of age, weighting 105.8 lb, was diagnosed with psychotic disorder and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: weight decreased. HALOPERIDOL dosage: unknown. Patient recovered.

Physician from UNITED STATES reported HALOPERIDOL problem on Dec 14, 2006. Female patient, 28 years of age, was diagnosed with schizoaffective disorder and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: pericardial effusion, pericarditis. HALOPERIDOL dosage: unknown. During the same period patient was treated with ZYPREXA, COGENTIN, DEPAKOTE ER, LEVAQUIN, ALBUTEROL, NEXIUM. Patient was hospitalized. Patient recovered.

HALOPERIDOL problem was reported by a Physician from FRANCE on June 07, 2007. Male patient, 53 years of age, was diagnosed with bipolar i disorder and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: pulmonary embolism. HALOPERIDOL dosage: unknown. During the same period patient was treated with NOCTAMIDE, TEGRETOL. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported HALOPERIDOL problem on July 06, 2007. Female patient, 82 years of age, was diagnosed with agitation and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: convulsion, dystonia. HALOPERIDOL dosage: 2 MG ONCE IV. During the same period patient was treated with PLAVIX, LEVOTHYROXINE, CALCIUM, NEURONTIN, CELEXA, ASPIRIN, VYTORIN, BUPROPION. Patient recovered.

HALOPERIDOL problem was reported by a Pharmacist from UNITED STATES on July 09, 2007. Male patient was diagnosed with bipolar disorder and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, dysarthria, neuroleptic malignant syndrome. HALOPERIDOL dosage: 5-10MG Q 6 HOURS PRN IV. During the same period patient was treated with LITHIUM CARBONATE. Patient recovered.

Pharmacist from UNITED STATES reported HALOPERIDOL problem on July 11, 2007. Female patient, weighting 115.0 lb, was diagnosed with psychotic disorder and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: neuroleptic malignant syndrome. HALOPERIDOL dosage: 5MG 2 DOSES INJ. Patient was hospitalized. Patient recovered.

HALOPERIDOL problem was reported by a Pharmacist from UNITED STATES on July 16, 2007. Male patient, 50 years of age, was diagnosed with schizophrenia, disorganised type and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: malaise. HALOPERIDOL dosage: 120 MG Q 4 WEEKS IM. Patient died on 07/02/2007.

Pharmacist from UNITED STATES reported HALOPERIDOL problem on July 13, 2007. Male patient, 50 years of age, was diagnosed with schizophrenia and was treated with HALOPERIDOL. HALOPERIDOL dosage: 1200MG/IV (TOTAL FOR BOTH LOTS). During the same period patient was treated with HALOPERIDOL DECANOATE. Patient died on 07/02/2007.

HALOPERIDOL problem was reported by a Pharmacist from UNITED STATES on July 24, 2007. Female patient, 39 years of age, was diagnosed with bipolar disorder and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: extrapyramidal disorder. HALOPERIDOL dosage: 5 MG Q4PRN IM. During the same period patient was treated with TRAZODONE, TEGRETOL. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported HALOPERIDOL problem on July 27, 2007. Male patient, 31 years of age, was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: dystonia. HALOPERIDOL dosage: 2MG PRN PO. Patient recovered.

HALOPERIDOL problem was reported by a Physician from JAPAN on Aug 06, 2007. Male patient, 59 years of age, was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased. HALOPERIDOL dosage: unknown. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported HALOPERIDOL problem on Aug 14, 2007. Male patient, weighting 116.0 lb, was diagnosed with schizophrenia, antiviral prophylaxis, hiv infection and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased. HALOPERIDOL dosage: unknown. During the same period patient was treated with HALDOL, TRUVADA, NORVIR, REYATAZ, COGENTIN. Patient recovered.

HALOPERIDOL problem was reported by a Physician from FRANCE on Aug 22, 2007. Female patient, 42 years of age, was diagnosed with schizophrenia and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: trismus. HALOPERIDOL dosage: unknown. Patient recovered.

Physician from CROATIA (local name: Hrvatska) reported HALOPERIDOL problem on Aug 16, 2007. Male patient, 44 years of age, was diagnosed with psychotic disorder, anxiety, depression, hallucination, insomnia, schizophrenia and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, hyperglycaemia, inappropriate antidiuretic hormone secretion, pancreatitis haemorrhagic. HALOPERIDOL dosage: 12 MG, DAILY, ORAL. During the same period patient was treated with DIAZEPAM, ALPRAZOLAM, PAROXETINE HYDROCHLORIDE, FLUPHENAZINE DECANOATE. Patient died.

HALOPERIDOL problem was reported by a Health Professional from ITALY on Aug 23, 2007. Female patient, 85 years of age, was diagnosed with psychomotor hyperactivity, diabetic neuropathy, abdominal pain upper and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, psychomotor hyperactivity, pulmonary congestion, renal failure acute, respiratory failure, rhabdomyolysis, somnolence. HALOPERIDOL dosage: 10 MG. During the same period patient was treated with GABAPENTIN, LANSOPRAZOLE, INSULIN LISPRO, RAMIPRIL, ASPIRIN, DILTIAZEM. Patient recovered.

Pharmacist from UNITED STATES reported HALOPERIDOL problem on Sept 13, 2007. Female patient, weighting 150.3 lb, was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: tachypnoea, wheezing. HALOPERIDOL dosage: unknown. Patient recovered.

HALOPERIDOL problem was reported by a Pharmacist from UNITED STATES on Sept 24, 2007. Female patient, 24 years of age, weighting 125.0 lb, was diagnosed with mania, paranoia and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: cogwheel rigidity, extrapyramidal disorder, eye rolling. HALOPERIDOL dosage: 7.5 MG PO. Patient recovered.

Pharmacist from UNITED STATES reported HALOPERIDOL problem on Sept 24, 2007. Female patient, 25 years of age, weighting 137.0 lb, was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: mental status changes, muscle rigidity, nuchal rigidity, oculogyric crisis, restlessness. HALOPERIDOL dosage: 5MG PRN PO 2 DOSES. Patient recovered.

HALOPERIDOL problem was reported by a Pharmacist from UNITED STATES on Sept 24, 2007. Male patient, 24 years of age, weighting 166.0 lb, was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: blepharospasm, musculoskeletal stiffness, parkinsonism, vision blurred. HALOPERIDOL dosage: 5 MG PO. Patient recovered.

Pharmacist from UNITED STATES reported HALOPERIDOL problem on Sept 25, 2007. Male patient, weighting 200.0 lb, was diagnosed with schizophrenia, depression and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: akathisia, dystonia, extrapyramidal disorder, facial palsy, mental disorder, musculoskeletal stiffness, speech disorder, tongue disorder. HALOPERIDOL dosage: 5MG BID PO. During the same period patient was treated with PAROXETINE. Patient recovered.

HALOPERIDOL problem was reported by a Physician from UNITED STATES on Sept 11, 2007. Male patient, 26 years of age, was diagnosed with bipolar disorder and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: dysarthria, dystonia, headache, joint dislocation, mastication disorder, weight decreased. HALOPERIDOL dosage: unknown. Patient recovered.

Physician from UNITED STATES reported HALOPERIDOL problem on Sept 11, 2007. Male patient, 26 years of age, was diagnosed with bipolar disorder and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: bipolar disorder, dystonia, headache, joint dislocation, weight decreased. HALOPERIDOL dosage: unknown. During the same period patient was treated with QUETIAPINE FUMARATE, MOOD STABILIZER. Patient recovered.

Showing 1-75 of 122 Next >

Ask Our Patient Community about HALOPERIDOL

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)
Pantoprazole
Paricalcitol
ParoxetineThis drug has as active FDA Safety Alert
PaxilThis drug has as active FDA Safety Alert (paroxetine)
Pegaptanib
Pegvisomant

Pemetrexed
PemolineThis drug has as active FDA Safety Alert
Pentobarbital and carbromal
Perflutren lipid microspheres
PerindoprilThis drug has as active FDA Safety Alert
PhenerganThis drug has as active FDA Safety Alert (promethazine)
Pimecrolimus

PioglitazoneThis drug has as active FDA Safety Alert
Placidyl (ethchlorvynol)
Plan B (levonorgestrel)
Pletal (cilostazol)
Poractant alfa
Posaconazole
Pramlintide Acetate
Precedex (dexmedetomidine)
PregabalinThis drug has as active FDA Safety Alert
Prezista (darunavir)
Prialt (ziconotide)
Priftin (rifapentine)
PrinivilThis drug has as active FDA Safety Alert (lisinopril)
ProcritThis drug has as active FDA Safety Alert (epoetin alfa)
ProHanceThis drug has as active FDA Safety Alert (gadoteridol)
PromethazineThis drug has as active FDA Safety Alert
PropofolThis drug has as active FDA Safety Alert
Prosom (estazolam)
Protonix (pantoprazole)
Protopic (tacrolimus)
Provigil (modafinil)
ProzacThis drug has as active FDA Safety Alert (fluoxetine)
Prussian blue


back to top

Q
Quazepam
Quetiapine

QuinaprilThis drug has as active FDA Safety Alert
Quinupristin

R
Rabeprazole
Radiogardase
(prussian blue)
Ramelteon
RamiprilThis drug has as active FDA Safety Alert
Ranexa (ranolazine)
Ranibizumab
Ranolazine
Rapamune (sirolimus)
Raptiva (efalizumab)
Rasagiline
RazadyneThis drug has as active FDA Safety Alert (galantamine)
Rebetol (ribavirin)
ReclastThis drug has as active FDA Safety Alert (zoledronic acid)
Refludan (lepirudin recombinant)
Relenza (zanamivir)
RelpaxThis drug has as active FDA Safety Alert (eletriptan)
RemeronThis drug has as active FDA Safety Alert (mirtazapine)
Renagel (sevelamer)
Rescula (unoprostone isopropyl)
Restoril (temazepam)
Revatio (sildenafil)
Revlimid (lenalidomide)
Reyataz (atazanavir sulfate)
Ribasphere (ribavarin ribasphere)
Ribavarin ribasphere
Rifapentine
Rifaximin
RisedronateThis drug has as active FDA Safety Alert
Risperdal (risperidone)
Risperidone
Ritalin (methylphenidate)
Ritonavir
RituxanThis drug has as active FDA Safety Alert
RituximabThis drug has as active FDA Safety Alert
Rivastigmine tartrate
RizatriptanThis drug has as active FDA Safety Alert
RocephinThis drug has as active FDA Safety Alert (ceftriaxone)
Rofecoxib
RosuvastatinThis drug has as active FDA Safety Alert
Rozerem (ramelteon)

back to top

S
Sacrosidase
Salmeterol xinafoate

Sanctura (trospium)
Seconal (secobarbital)
Secobarbital
Selzentry
Sensipar (cinacalcet)
Serevent Diskus (salmeterol xinafoate)
Seroquel (quetiapine)
Sertaconazole
SertralineThis drug has as active FDA Safety Alert
SerzoneThis drug has as active FDA Safety Alert (nefazodone)
Sevelamer
Sildenafil citrate
Sirolimus
Simvastatin
Sitagliptin phosphate
SkelidThis drug has as active FDA Safety Alert (tiludronate)
Sodium ferric gluconate complex
Sodium phosphatesThis drug has as active FDA Safety Alert
Solage (mequinol; tretinoin)
Soliris (eculizumab)
Solifenacin succinate
Somavert (pegvisomant)
Sonata (zaleplon)
Sorafenib
SotretThis drug has as active FDA Safety Alert (isotretinoin)
Spectracef (cefditoren pivoxil)
Spiriva (tiotropium bromide)
Sprycel (dasatinib)
Starlix (nateglinide)
Stimate Nasal SprayThis drug has as active FDA Safety Alert(desmopressin)
StratteraThis drug has as active FDA Safety Alert (atomoxetine)
Sucraid (sacrosidase)
SumatriptanThis drug has as active FDA Safety Alert
Sunitinib